- Home
- OFG vs JANX Comparison
OFG vs JANX Comparison
Compare OFG & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFG
- JANX
- Stock Information
- Founded
- OFG 1964
- JANX 2017
- Country
- OFG United States
- JANX United States
- Employees
- OFG N/A
- JANX N/A
- Industry
- OFG Major Banks
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- OFG Finance
- JANX Health Care
- Exchange
- OFG Nasdaq
- JANX Nasdaq
- Market Cap
- OFG 1.8B
- JANX 1.6B
- IPO Year
- OFG N/A
- JANX 2021
- Fundamental
- Price
- OFG $41.23
- JANX $25.56
- Analyst Decision
- OFG Buy
- JANX Strong Buy
- Analyst Count
- OFG 3
- JANX 7
- Target Price
- OFG $44.00
- JANX $94.29
- AVG Volume (30 Days)
- OFG 338.8K
- JANX 929.3K
- Earning Date
- OFG 04-23-2025
- JANX 05-08-2025
- Dividend Yield
- OFG 2.90%
- JANX N/A
- EPS Growth
- OFG 6.67
- JANX N/A
- EPS
- OFG 4.18
- JANX N/A
- Revenue
- OFG $623,009,000.00
- JANX $9,336,000.00
- Revenue This Year
- OFG $0.52
- JANX N/A
- Revenue Next Year
- OFG $3.97
- JANX $250.58
- P/E Ratio
- OFG $9.90
- JANX N/A
- Revenue Growth
- OFG N/A
- JANX 28.12
- 52 Week Low
- OFG $33.15
- JANX $22.52
- 52 Week High
- OFG $47.66
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- OFG 63.04
- JANX 37.10
- Support Level
- OFG $40.32
- JANX $24.13
- Resistance Level
- OFG $42.24
- JANX $33.97
- Average True Range (ATR)
- OFG 1.08
- JANX 2.01
- MACD
- OFG 0.48
- JANX -0.61
- Stochastic Oscillator
- OFG 85.17
- JANX 14.53
About OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.